Advertisement

Theoretical and Clinical Aspects of the Tourette Syndrome (Chronic Multiple Tic)

  • R. Fog
  • H. Pakkenberg
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 16)

Abstract

In three schizophrenic patients long-term neuroleptic treatment induced Tourette-like symptoms. There seems to be a partial overlap in the pathogenesis of Tourette Syndrome and tardive dyskinesia.

In five Tourette patients treatment with pimozide was very effective inducing only few side-effects. Long-term neuroleptic treatment may, however, aggravate the symptoms in the long run.

A eombination treatment with tetrabenazine and pimozide is suggested.

Keywords

Schizophrenic Patient Tardive Dyskinesia Tourette Syndrome Rheumatic Fever Neuroleptic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Butler, I. J., Koslow, S. H., Seifert, W. E. Biogenic aminemetabolism in Tourette Syndrome. Ann. Neurol. 6 37–39 (1979).PubMedCrossRefGoogle Scholar
  2. Brunn, R. D., Shapiro, A. K A followup of 7 patients with Gilles de la Tourette Syndrome. Am. J. Psychiatry 133, 944–947 (1976).Google Scholar
  3. Christensen, A. V., Meiler, N. L Dopaminergic supersensitivity: Influence of dopamine agonists, cholinergics, anticholinergics and drugs used for the treatment of tardive dyskinesia. Psychopharmacology62 111–116 (1979).PubMedCrossRefGoogle Scholar
  4. Fog, R., Pakkenberg, H.: Combined nitoman-pimozide treatment of Huntington’s chorea and other hyperkinetic syndromes. Acta neurol. scand. 46 249–251 (1970).PubMedCrossRefGoogle Scholar
  5. Fog, R., Pakkenberg, H.Combination treatment of hyperkinetic syndromes with tetrabenazine and pimozide. In: Tardive Dyskinesia Davis, J. M., Fann, W. E., Smith, R. C., eds.). New York: Spectrum Publications. 1979, in press.Google Scholar
  6. Gerlach J Tardive dyskinesia. Dan. Med. Bull. 26209–245 (1979).PubMedGoogle Scholar
  7. Gibson, A.: A comparison of different neuroleptic drugs and different ways of using neuroleptic drugs in the treatment of early tardive dyskinesia. In: Phenothiazines and Structurally Related Drugs. Basic and Clinical Studies Usdin, E., Eckert, H., Forrest, J., eds.). New York: Elsevier North-Holland. 1979 (in press)Google Scholar
  8. Pakkenberg, H., Fog, R Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both. Arch. Neurol. 31, 352–353 (1974).PubMedCrossRefGoogle Scholar
  9. Pakkenberg, H., Fog, R., Nilakantan, B The long-term effect of Perphenazine enanthate on the rat brain. Some metabolic and anatomical observations. Psychopharmacologia (Berl.) 29, 329–336 (1973).CrossRefGoogle Scholar
  10. Snyder, S. H., Taylor, K. M., Coyle,J. T., The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs. Am. J. Psychiatry 127 199–207 (1970).PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • R. Fog
    • 1
    • 2
  • H. Pakkenberg
    • 1
    • 2
    • 3
  1. 1.Department E, Roskilde,Laboratory of NeurologySt.Hans HospitalDenmark
  2. 2.Hvidovre HospitalDenmark
  3. 3.Department E, Roskilde,Laboratory of NeurologySt.Hans Hospital, Hvidovre HospitalHvidovreDenmark

Personalised recommendations